Skip to content
Open access · US-GOV via ClinicalTrials.gov Clinical trial

Vielight Neuro RX Gamma Photobiomodulation Device for Moderate to Severe Alzheimer's Disease

Authors not listed

Vielight Inc. · 2019

Abstract

The active Neuro RX Gamma device uses non-invasive near-infrared energy delivered to the brain with the intention to improve cognitive functioning and quality of life in patients with moderate to severe Alzheimer's Disease. Treatment will occur at home-based treatment sessions with the device.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
ClinicalTrials.gov
Canonical
link ↗
Fetched
2026-11-01 MST

Cite this

APA
Anonymous. (2019). Vielight Neuro RX Gamma Photobiomodulation Device for Moderate to Severe Alzheimer's Disease. <em>Vielight Inc.</em>. https://clinicaltrials.gov/study/NCT03484143
Vancouver
Anonymous. Vielight Neuro RX Gamma Photobiomodulation Device for Moderate to Severe Alzheimer's Disease. Vielight Inc.. 2019.
BibTeX
@misc{anon2019Vielig, title = {Vielight Neuro RX Gamma Photobiomodulation Device for Moderate to Severe Alzheimer's Disease}, author = {Anonymous}, journal = {Vielight Inc.}, year = {2019}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings